Triopsy

Aurora, United States Founded: 2012 • Age: 14 yrs
Medical device for precise prostate cancer diagnosis is developed.

About Triopsy

Triopsy is a company based in Aurora (United States) founded in 2012.. Triopsy has raised $4.14 million across 7 funding rounds from investors including Colorado Office of Economic Development and International Trade. Triopsy offers products and services including Triopsy Biopsy System, Specimen Transport, and Renaissance LIS Software. Triopsy operates in a competitive market with competitors including Exact Imaging, KOELIS, Exact Imaging, Clariflow and Focal Healthcare, among others.

  • Headquarter Aurora, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name Triopsy Medical, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Triopsy

Triopsy offers a comprehensive portfolio of products and services, including Triopsy Biopsy System, Specimen Transport, and Renaissance LIS Software. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Captures more tissue for accurate prostate cancer diagnosis and reduces errors.

Preserves and transports biopsy samples intact to prevent misdiagnosis.

Manages biopsy samples and generates customized pathology reports efficiently.

Funding Insights of Triopsy

Triopsy has successfully raised a total of $4.14M across 7 strategic funding rounds. The most recent funding activity was a Seed round of $100 thousand completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 7
  • Last Round Seed — $100,000
  • First Round

    (11 Feb 2016)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2024 Amount Seed - Triopsy Valuation

investors

Mar, 2023 Amount Seed - Triopsy Valuation

investors

May, 2022 Amount Seed - Triopsy Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Triopsy

Triopsy has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Colorado Office of Economic Development and International Trade. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Economic development and international trade are facilitated for Colorado businesses.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Triopsy

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Triopsy

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Triopsy Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Triopsy

Triopsy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Exact Imaging, KOELIS, Exact Imaging, Clariflow and Focal Healthcare, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Micro-ultrasound devices for prostate imaging and biopsies are developed.
domain founded_year HQ Location
MRI/ultrasound fusion biopsy systems for prostate care are developed.
domain founded_year HQ Location
Prostate cancer imaging is enabled by micro-ultrasound technology.
domain founded_year HQ Location
Provides DIY test kits for benign prostatic hyperplasia (BPH).
domain founded_year HQ Location
MRI/TRUS fusion systems for prostate biopsy guidance are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Triopsy

Frequently Asked Questions about Triopsy

When was Triopsy founded?

Triopsy was founded in 2012 and raised its 1st funding round 4 years after it was founded.

Where is Triopsy located?

Triopsy is headquartered in Aurora, United States. It is registered at Aurora, Colorado, United States.

Who is the current CEO of Triopsy?

David G Bostwick is the current CEO of Triopsy.

Is Triopsy a funded company?

Triopsy is a funded company, having raised a total of $4.14M across 7 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Feb 11, 2016.

What does Triopsy do?

Triopsy was founded in 2012 and is headquartered in Aurora, United States. Operations focus on the medical device sector, where a system integrating biopsy and pathology technologies is utilized for identifying tumor locations, disease types, stages, and genomic profiles. This aids in diagnosis and treatment planning for prostate cancer, supporting pathways to personalized medicine.

Who are the top competitors of Triopsy?

Triopsy's top competitors include KOELIS, Exact Imaging and Exact Imaging.

What products or services does Triopsy offer?

Triopsy offers Triopsy Biopsy System, Specimen Transport, and Renaissance LIS Software.

Who are Triopsy's investors?

Triopsy has 1 investor. Key investors include Colorado Office of Economic Development and International Trade.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available